Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...

Roughly 16 million American adults are taking GLP-1 medications. They are a major breakthrough for people to shed pounds and ...

New research published Tuesday concludes that the rising rate of extreme childhood obesity—well above the usual BMI ...

A MUM who slimmed down five dress sizes thanks to Mounjaro has shared her top tips for those wanting to shed weight with fat jabs. Katie McCutcheon, from Glasgow, Scotland, who lost over 5st in ...

Biocon aims to introduce generic versions of the obesity drug Wegovy in India and Canada by late 2026 or early 2027, ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years, a top executive told Reuters ...

The company will offer a generic version of semaglutide in the country after Novo Nordisk let its patent expire there. Hims & ...

Biocon plans to launch generic copies of Wegovy in India and Canada within two years, targeting a growing drug market ...

Biocon plans to introduce generic versions of the weight-loss drug Wegovy in India and Canada by 2027, according to CEO Siddharth Mittal.

The launch of GLP-1 weight loss drugs in India is gaining popularity. Harvard researchers share a comprehensive guidance for ...